Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical...

93
Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW

Transcript of Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical...

Page 1: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Clinical Approach to New Onset Arthritis

Jeffrey Carlin, MD Division of Rheumatology, VMMCClinical Associate Professor, UW

Page 2: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Nothing to declare

Page 3: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Acute Arthritis• The sudden onset of inflammation of the joint,

causing severe pain, swelling, and redness.• Structural changes in the joint itself may result

from persistence of this condition.

Page 4: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Key Points1. Distinguish arthritis from soft tissue non- articular

syndromes (discrepancy between “active” and “passive” ROM suggests periarticular/soft tissue)

2. If the problem is articular distinguish single joint from multiple joint involvement

3. Inflammatory or non-inflammatory disease4. Always consider septic arthritis!

Page 5: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Inflammatory Vs. Noninflammatory

Feature Inflammatory Noninflammatory

Pain (when?)

Swelling

Erythema

Warmth

AM stiffness

Systemic features

î ESR, CRP

Synovial fluid WBC

Examples

Yes (AM)

Soft tissue

Sometimes

Sometimes

Prominent

Sometimes

Frequent

WBC >2000

Septic, RA, SLE, Gout

Yes (PM)

Bony

Absent

Absent

Minor (< 30 ‘)

Absent

Uncommon

WBC < 2000

OA, AVN

Page 6: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Acute Monoarthritis• Inflammation (swelling, tenderness,

warmth) in one joint• Occasionally polyarticular diseases can

present with monoarticular onset: (RA, JRA,Reactive and enteropathic arthritis, Sarcoid

arthritis, Viral arthritis, Psoriatic arthritis)

Page 7: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Acute Monoarthritis - Etiology

• THE MOST CRITICAL DIAGNOSIS TO CONSIDER: INFECTION !

Page 8: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Acute Monoarthritis - Etiology

• Septic• Crystal deposition (gout, pseudogout)• Traumatic (fracture, internal derangement)• Other (hemarthrosis, osteonecrosis,

presentation of polyarticular disorders)

Page 9: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Questions to Ask – History Helps in Differential Diagnosis

• Pain come suddenly, minutes? – fracture.• 0ver several hours or 1-2 days? –infectious, crystals,

inflammatory arthropathy.• History of IV drug abuse or a recent infection? –

septic joint.• Previous similar attacks? – crystals or inflammatory

arthritis.• Prolonged courses of steroids? – infection or

osteonecrosis of the bone.

Page 10: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Acute Monoarthritis

Page 11: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Indications for Arthrocentesis

– SYNOVIAL FLUID ANALYSIS: The single most useful diagnostic study in initial evaluation of monoarthritis

– 1. Suspicion of infection– 2. Suspicion of crystal-induced arthritis– 3. Suspicion of hemarthrosis– 4. Differentiating inflammatory from

noninflammatory arthritis

Page 12: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Tests to Perform on Synovial Fluid

• Gram stain and cultures • Total leukocyte count/differential

– Inflammatory vs. non-inflammatory• Polarized microscopy to look for crystals• Not necessary routinely:

– Chemistry (glucose, total protein, LDH) unlikely to yield helpful information beyond the previous tests.

Page 13: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Synovial Fluid Analysis

Joint Fluid Appearance Cell Count

Normal Clear/Yellow <200 WBC’s

Non-Inflammatory

Clear/Yellow <2000 WBC’s

Inflammatory Turbid/Yellow <50,000 WBC’s

Septic Pus >50,000 WBC’s

Page 14: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Other Tests Indicated for Acute Arthritis

1. Almost always indicated: RadiographsCBCESR/CRP

2. Indicated in certain patients: Cultures

3. Rarely indicated: Serologic: ANA, RF, HLA-B27Serum Uric acid level

Page 15: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Tests of Acute Phase Reactants

• Erythrocyte Sedimentation Test• C-Reactive Protein

Page 16: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Patterns of Response of Acute Phase Reactants

Gabay C, Kushner I, NEJM , 1999;340:450

Page 17: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

ESR’s

• Non-specific marker- elevated in rheumatic diseases, infection, malignancy

• Can be artificially elevated by:• Pregnancy• Anemia• Nephrotic Syndrome• Benign/Malignant Monoclonal Gammopathies• Age• Obesity

• Can be normal in some inflammatory conditions

Page 18: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Formula for Age- Related Normals

• Men: ESR(mm/hr)= (age in years)/2

• FemalesESR (mm/hr)= (age in years + 10)/2

Page 19: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

C- Reactive Protein

• Produced in liver in response to IL-1 & IL-6

• Rapid rise in response to inflammatory stimuli • Can be affected by:

– Obesity/Metabolic Syndrome– Age

Page 20: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Formula for Age-Related Normals

• Men CRP = (age/65) +.1 mg/dl

• WomenCRP = (age/65) + .7 mg/dl

Page 21: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Septic Joint• Most articular infections – a single joint• 15-20% cases polyarticular• Most common sites: knee, hip, shoulder• 20% patients afebrile• Joint pain is moderate to severe• Joints visibly swollen, warm, often red• Comorbidities: RA, DM, SLE, cancer,etc

Page 22: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Septic Joint - Nongonococcal

• 80-90% monoarticular• Most develop from hematogenous spread• Most common:

– Gram positive aerobes (80%)– Majority with Staph aureus (60%)– Gram negative 18%

Page 23: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Likely Causes of Septic ArthritisGram Stain Pt Characteristic Organism of Concern

No Bacteria Young, healthy GC, Staph

No Bacteria Hx of RA Staph

No bacteria Immunosupression, IV drugs, Hx gm- infection

Staph, Strep, Pseudomonas,

fungal

No Bacteria or Gm - Recent cat/dog bite Pasteurella multocida

Gm+ None Staph/Strep

Gm- diplococci None GC ( consider meningococcemia)

Gm - None Rx for possible pseudomonas

Gm - SLE or Sickle Cell Include coverage for Salmonella & Psudomonas

No bacteria Hx prosthetic joint Staph epidermidis, Staph aureus

No bacteria HX fresh/salt H20 exposure + injury; chronic swelling

Mycobacterium marinum

Page 24: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Initial Empirical Antibiotic RxGram Stain Drug of Choice Alternative Drug

Gm + Cocci (small) in pairs & chains

Vancomycin 1 gm IV 12 h Cefotaxime 2.0 gm Iv q6-8h

Gm+ Cocci (large) singly or in large groups

Vancomycin 1 gm IV q12 h Nafcillen 2.0gm Iv q 4h

Gm - Bacilli Ceftriaxone 2.0 gm q 24h Imipenem .5 gm IV q 6h

Gm- Bacilli Cefotaxime 2.0 gm IV q 6h Imipenem .5 gm IV q 6h

None- (Healthy young pt- Assume GC but include Gm + coverage

Ceftriaxone 2.0 gm q 24h Imipenem .5 gm IV q 6h

None- (Underlying disease or Immunosupression

Vancomycin 1 gm IV 12 h + Cipro 400mg q 12 h

Imipenem .5 gm IV q 6h

Page 26: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Gout• Caused by monosodium urate crystals• Most common type of inflammatory monoarthritis• Typically: first MTP joint, ankle, midfoot, knee• Pain very severe; cannot stand bed sheet• May be with fever and mimic infection• The cutaneous erythema may extend beyond the

joint and resemble bacterial cellulitis

Page 27: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Urate Crystals

• Needle-shaped

• Strongly negative birefringent

Page 28: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Gouty Arthritis

Page 29: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Pseudogout

Page 30: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Pseudogout• Can cause monoarthritis clinically indistinguishable

from gout.• Often precipitated by illness or surgery.• Pseudogout is most common in the knee (50%) and

wrist.• Reported in any joint (Including MTP).• CPPD disease may be asymptomatic (deposition of

CPP in cartilage).

Page 31: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

CPPD Crystals

• Rod or rhomboid-shaped

• Weakly positive birefringent

Page 32: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Algorithm for w/u of Monoarticular Arthritis

Page 33: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Polyarthritis• Definite inflammation (swelling,

tenderness, warmth of > 5 joints• A patient with 2-4 joints is said to

have pauci- or oligoarticular arthritis

Page 34: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Acute PolyarthritisInfection• Gonococcal• Meningococcal• Lyme disease• Rheumatic fever• Bacterial endocarditis• Viral (rubella,

parvovirus, Hep. B)

Page 35: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Acute PolyarthritisInfection• Gonococcal• Meningococcal• Lyme disease• Rheumatic fever• Bacterial endocarditis• Viral (rubella,

parvovirus, Hep. B)

Inflammatory• RA• JRA• SLE• Reactive arthritis• Psoriatic arthritis• Polyarticular gout• Sarcoid arthritis

Page 36: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Inflammatory Vs. Noninflammatory

Feature Inflammatory Mechanical

Morning stiffness

Fatigue

Activity

Rest

Systemic

Corticosteroid

>1 h

Profound

Improves

Worsens

Yes

Yes

< 30 min

Minimal

Worsens

Improves

No

No

Page 37: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Temporal Patterns in Polyarthritis

• Migratory pattern: – Rheumatic fever, gonococcal (disseminated

gonococcemia), early phase of Lyme disease

• Additive pattern – RA, SLE, psoriasis

• Intermittent: – Gout, reactive arthritis

Page 38: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Patterns of Joint Involvement

• Symmetric polyarthritis involving small and large joints: viral, RA, SLE, one type of psoriatic (the RA-like).

• Asymmetric, oligo- and polyarthritis involving mainly large joints, preferably lower extremities, especially knee and ankle : reactive arthritis, one type of psoriatic, enteropathic arthritis.

• DIP joints: Psoriatic.

Page 39: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Acute Polyarthritis - RA

Page 40: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Rheumatoid Arthritis• Symmetric, inflammatory polyarthritis, involving

large and small joints• Acute, severe onset 10-15 %; subacute 20%• Hand characteristically involved• Acute hand deformity: fusiform swelling of fingers

due to synovitis of PIPs• RF/Anti-CCP Ab may be negative at onset and

may remain negative in 15-20%! • RA is a clinical diagnosis, no laboratory test is

diagnostic, just supportive!

Page 41: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Rheumatoid Factors

Page 42: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Rheumatoid Factors

• Autoantibodies to the Fc portion of IgG. • Support a diagnosis of Rheumatoid Arthritis but

are not by themselves diagnostic. • Are seen in about 75% to 80% of patients with RA. • Are associated with a poor prognosis in patients

with RA. • Are seen in conditions other than RA

Page 43: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Rheumatic Diseases with Positive RF

• RA 80%• JRA 20%• SLE 20%• Sjogren’s 90%• Scleroderma 20-30%

Page 44: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Non-Rheumatic Diseases with Positive RF

• Hepatitis C < 70%• Mixed cryoglobulinemia 90%• Sarcoidosis 5-30%• Pulmonary Fibrosis 20%• Infections varies• Aging 5%

Page 45: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

RF: Clinical Significance• Highly predictive of RA in patients with identified rheumatic

disease• May be absent at the onset of disease in up to half of patients

with typical clinical picture of RA– approx 20% remain seronegative– many convert within 2 years

• Best used to confirm RA for typical presentation– inflammatory polyarthritis, “gel phenomenon,” etc.

• Not useful to follow course of illness– generally not helpful to repeat after diagnosis

Page 46: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

RF: Test Statistics

• Sensitivity 80%• Specificity 95%• PPV (unselected populations)- 20-30%

(RA population)- 80%• NPV- 95%

Page 47: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Anti-Citrulline Antibody Assay

ELISA detects antibodies to cyclic citrullinated protein (anti-CCP)

Page 48: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Anti-CCP Antibody Assay

• Accuracy (Anti-CCP-2 Assay)– Specificity 79% Sensitivity 96-98%

• Diagnosis more accurate when combined with RF+• Present in 50-60% early RA patients• Can be seen 1.5 -9 yrs pre-diagnosis of RA• Predictive for progressive joint damage

– Present in up to 40% percentage of RF- patients with erosions

– RF+, anti-CCP+ pts have very aggressive disease

Page 49: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Viral Arthritis• Younger patients• Usually presents with prodrome, rash• History of sick contact• Polyarthritis similar to acute RA• Prognosis good; self-limited• Examples: Parvovirus B-19, Rubella, Hepatitis

B and C, Acute HIV infection, Epstein-Barr virus, mumps

Page 50: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Parvovirus B-19• The virus of “fifth disease”, erythema infectiosum

(EI).• Children “slapped cheek”; adults flu-like illness,

maculopapular rash on extremities.• Joints involved more in adults (20% of cases).• Frequently RF +• Abrupt onset symmetric polyarthralgia/polyarthritis

with stiffness in young women exposed to kids with E.I.

• May persist for a few weeks to months.

Page 51: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Spondyloarthropathy

Undifferentiated spondyloarthropathy

Arthritis associated with

inflammatory bowel disease

Psoriatic arthritis

Ankylosing spondylitis

Reactive arthritis

Page 52: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Inflammatory Back Pain

• Onset of back discomfort before age 40• Insidious onset• > 3 mths duration• Morning stiffness in the back• Improvement with exerciseIf 4 of these are met, AS is diagnosed

Page 53: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Techniques for Imaging SIJ

Benefits Shortcomings

X-ray Quick & cheap Changes occur late

Radionuclide imaging

May indicate early changes Controversial

CT Clear imaging of early changes, may clarify dx when x-ray borderline

Radiation dose

Very early disease may still not be

detectable

MRI May show inflammation & very early changes

Price & availability

Page 54: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Asymmetric, Inflammatory Oligoarthritis

Page 55: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Enthesitis in Spondyloarthropathies

Page 56: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Reactive Arthritis

• Triggered by specific gut or genito-urinary tract infections

– Salmonella, Yersinia, Campylobacter, Shigella– Chlamydia

• Joint symptoms appear 1-3 week later– Oligoarthritis; usually lower extremity– Enthesitis

• Frequent association with extra-articular findings• A proportion evolve into chronic spondyloarthropathy

Page 57: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Extra-articular Features of Reactive Arthritis

• Don’t be put off if they are not present• Ask about GI disturbance - even mild• Ask about conjunctivitis• Take a sexual history (with explanation)• Examine eyes and skin (soles/external

genitalia)• Look for enthesitis

Page 58: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Psoriatic Arthritis

Page 59: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Psoriatic Arthritis• Prevalence of arthritis in Psoriasis 10-20%

– Psoriasis usually precedes PSA- 75%– 10-15% arthritis precedes Psoriasis– Nail changes common

• Psoriatic plaques– Scalp, extensor surfaces, natal cleft,

umbilicus

Page 60: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Psoriatic Arthritis

• Subtypes:– Asymmetric, oligoarticular- associated dactylitis– Predominant DIP involvement – nail changes– Polyarthritis “RA-like” – lacks RF or nodules– Arthritis mutilans – destructive erosive hands/feet– Axial involvement –spondylitis– HIV-associated – more severe

Page 61: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Dactylitis “Sausage Toes” – Psoriasis

Page 62: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Nail Changes in Psoriatic Arthritis

Page 63: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Nail Pitting - Psoriasis

Page 64: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

European Criteria for Spndyloarthropathy

• Inflammatory spine pain or synovitis• And one or more of the following:

• Alternating buttocks pain• Sacroiliitis• Enthesopathy• Positive family history• Psoriasis• IBD• Recent episode of urethritis/cervicitis or

gastroenteritis

Page 65: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

HLA-B27 in the General Population

• Caucasian 6-8%• African-Americans 4%• African Blacks 0%• Japanese 1%• Koreans 3-4%• Native Americans 40-50%

(Haida, Navajo, Eskimos)

Page 66: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

HLA- B27 and Disease(Caucasians)

Disease Association Ankylosing spondylitis 90%

Reactive arthritis 60-80%

Inflammatory bowel disease 35-75%

Psoriatic arthritis

With spondylitis 50%

With peripheral arthritis 15%

Undifferentiated Spondyloarthropathy 70%

Anterior Uveitis 50%

Page 67: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.
Page 69: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Acute Sarcoid Arthritis• Löfgren’s syndrome: acute arthritis, erythema

nodosum, bilateral hilar adenopathy• Chronic arthritis- (15-20%)

– Symmetrical: wrists, pip’s, ankles, knees

• Chronic inflammatory disorder – noncaseating granulomas at involved sites

• Common with hilar adenopathy

Page 70: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

1. Wolfe F, et al Arthritis Care and Research 2010;62; 600-6102. Wolfe, F et al, Arth & Rheum 1990; 33:160-172

Page 71: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Prognosis of Early Undifferentiated Arthritis

• Remission- 13-60%• RA or other Dx- 7-65%• Persistant Disease w/o DX- 10-40%

• Monoarticular Arthritis– Remission- 60%– Oligoarticular- 10-40%– Undifferentiated-70%

Page 72: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Thank you!

Page 73: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Arthritis Of SLE• Musculoskeletal manifestation 90%.• Most have arthralgia.• May have acute inflammatory synovitis RA-

like.• Do not develop erosions.• Other clinical features help with DD: malar

rash, photosensitivity, rashes, alopecia, oral ulceration.

Page 74: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Butterfly Rash – SLE

Page 75: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Photosensitivity

Page 76: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Alopecia - SLE

Page 77: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Arthritis of Rheumatic Fever

• Etiology: Streptococcus pyogenes (group A); there is damaging immune response to antecedent infection – molecular cross reaction with target organs “molecular mimicry”.

• Onset approximately 3wks after exposure• Migratory polyarthritis, large joints: knees, ankles,

elbows, wrists.• Major manifestations: carditis, polyarthritis, chorea,

erythema marginatum, subcutaneous nodules.

Page 78: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Erythema Marginatum – Rheumatic Fever

• Circinate• Evanenscent• Nonpruritic rash

Page 79: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Rheumatic Fever – Subcutaneous Nodes

Page 80: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Post-Strep Reactive Arthritis

• Onset 7-10 days after Strep A• Oligoarthritis lasting >3weeks• Evidence for recent infection: Throat culture,

+ASO titers

Page 81: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Adult Still’s Disease and JRA Rash

• Salmon or pale-pink • Blanching• Macules or

maculopapules• Transient (minutes or

hours)• Most common on

trunk• Fever related

Page 82: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Disseminated Gonococcemia – Pustules

Page 83: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Septic Joint - Gonococcal

• Most common cause of septic arthritis• Often preceded by disseminated gonococcemia• Sexually active individual, 5-7 days h/o fever, chills,

skin lesions, migratory arthralgias and tenosynovitis persistent monoarthritis

• Women often menstruating or pregnant• Genitourinary disease often asymptomatic

Page 84: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Viral Arthritides - Parvovirus

Page 85: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Rubella Arthritis• German measles.• Young women exposed to school-aged children.• Arthritis in 1/3 of natural infections; also following

vaccination.• Morbilliform rash, constitutional symptoms.• Symmetric inflammatory arthritis (small and large

joints).

Page 86: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

1987 ACR Criteria for Rheumatoid Arthritis

• 4/7 Criteria– AM Stiffness lasting > 1 hr– Swelling in >3 joint areas simultaneously– Swelling in Wrist, MCP or PIP joint– Symmetrical Arthritis– Rheumatoid Nodules– Positive RF (or Anti-CCP AB)– XRay Changes

Page 87: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Keratoderma Blenorrhagicum

Page 88: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Circinate Balanitis – Reactive Arthritis

Page 89: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Reactive Arthritis - Conjunctivitis

Page 90: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Reactive Arthritis – Palate Erosions

Page 91: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Recent Prevalence Studies of AS and Related Diseases

(Khan, MA, Annals of Internal Medicine.2002;136:896-907)

Ethnic Groupor Region

Frequencyof

HLA-B27 inPopulation

Prevalence of AS inAdults

Prevalence of AllSpondyloarthropathies inAdults

GeneralPopulation

HLA-B27PositivePersons

GeneralPopulation

HLA-B27PositivePersons

Eskimos 40 0.4 2.5Eskimos(Alaska &Siberia) +Chukchi

25-50 1.6 2-3.4 4.2

Sami 24 1.8 6.8NorthernNorway

10-16 1.4

Mordovia 16 0.5WesternEurope

8 0.2 2

Germany(Berlin)

9 0.9 6.4 1.9 13.6

Page 92: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Lyme Disease

Page 93: Clinical Approach to New Onset Arthritis Jeffrey Carlin, MD Division of Rheumatology, VMMC Clinical Associate Professor, UW.

Lyme Arthritis• Erythema migrans 7-10 days after Borrelia

burgdorferi tick bite• Early dissemination-

– Migratory arthralgias, fever, systemic complaints

• Late dissemination/Chronic disease-– Migratory oligoarthritis– Carditis– Neurological